[2-(1H-pyrazol-1-yl)ethyl]amine dihydrochloride, 95.0%, 5g

3-Bromo-2-chloro-5-methylpyridine>96.0%(GC)5g

4-Piperidinecarboxamide, 98.0%, 500g

1-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)INDOLIN-2-ONE, 95.0%, 5g

4-Ethoxycarbonylphenoxytetrafluorobromoethane, 95.0%, 1g

Copper wire, annealed 99.998% 0.125 mm diameter 25 m

Ethyl 3-aminocrotonate, 99.0%, 500g

2-methoxy-1-(1-methyl-1H-pyrazol-5-yl)ethanone, 95.0%, 1g

4-(2,6-di-tert-butyl-4-((2-((3,5-di-tert-butyl-4-hydroxyphenyl)thio)propan-2-yl)thio)phenoxy)-4-oxobutanoic acid, 98%, 25mg

Phase contrast slide with phase rings for PLPH 20x and S100x oil plan phase objectives

1-[2-(2-Hydroxyethoxy)ethyl]piperazine, 95.0%, 25g

4-Fluoro-1H-indol-5-ol, 95.0%, 100mg

cis-1,2-Dicyano-1,2-bis(2,4,5-trimethyl-3-thienyl)ethene>98.0%(N)5g